Vancomycin-resistant enterococcal colonization in nonhospitalized HIV-infected patients

West J Med. 1998 Nov;169(5):276-9.

Abstract

We studied fecal colonization with vancomycin-resistant enterococci (VRE) in 89 HIV-infected nonhospitalized patients ages 24 to 62 years, including 70 (79%) men (including 41 homosexual and 5 bisexual men) and 19 (21%) women. Of the 89 patients, 61 (69%) were black, 25 (28%) Hispanic, and 3 (3%) white; 53 (60%) had history of ongoing or recent antibacterial therapy with trimethoprim/sulfamethoxazole (29), clarithromycin (18), amoxicillin (7), ofloxacin (3), and metronidazole, doxycycline, dicloxacillin, and cephalexin (1 each). VRE were not isolated from any of the patients studied.

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy*
  • Adult
  • Amoxicillin / therapeutic use
  • Anti-Bacterial Agents / therapeutic use*
  • Bisexuality
  • Black People
  • Cephalexin / therapeutic use
  • Cephalosporins / therapeutic use
  • Clarithromycin / therapeutic use
  • Dicloxacillin / therapeutic use
  • Doxycycline / therapeutic use
  • Drug Resistance, Microbial
  • Enterococcus / drug effects*
  • Feces / microbiology
  • Female
  • Gram-Positive Bacterial Infections / drug therapy*
  • Homosexuality, Male
  • Humans
  • Male
  • Metronidazole / therapeutic use
  • Middle Aged
  • Ofloxacin / therapeutic use
  • Penicillins / therapeutic use
  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use
  • Vancomycin / therapeutic use*
  • White People

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • Penicillins
  • Metronidazole
  • Vancomycin
  • Amoxicillin
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Ofloxacin
  • Dicloxacillin
  • Clarithromycin
  • Doxycycline
  • Cephalexin